PhRMA revises guidelines for clinical trials
Pharma Compliance Alert, April 29, 2009
Pharmaceutical companies should provide results summaries for all interventional clinical trials involving patients, according to revised industry guidance.
Companies should publish the summaries whether the FDA approves the medicines or the particular research programs have been discontinued
Read more about PhRMA's revised guidelines for clinical trials.
Related Products
Most Popular
- Articles
-
- Q/A: Billing telemetry daily monitoring
- Credentialing monthly: What is the role of the credentials committee in addressing unprofessional conduct?
- 2010 ICD-9 code updates now available online
- Master modifiers to ensure accurate reimbursement
- Radiologist indicted for fraudulently signing reports
- National Quality Forum creates standardized set of data for electronic health records
- H1N1 hits Maine facility
- New report reveals $47 billion in Medicare fraud
- Understand the H1N1 Flu and how to code it
- Don’t be scared into silence: Affiliation letter safeguards allow you to disclose more
- E-mailed
-
- Q/A: Billing telemetry daily monitoring
- Credentialing monthly: What is the role of the credentials committee in addressing unprofessional conduct?
- Radiologist indicted for fraudulently signing reports
- Revised MS.1.20 'huge improvement', out for comment again
- Briefings on Outpatient Rehab Reimbursement and Regulations, December 2009
- New report reveals $47 billion in Medicare fraud
- Press Ganey report: Patient satisfaction increasing across the country
- Residency Program Alert, December 2009
- CMW News: Palliative care programs save hospitals money
- How Unions are Using the Sherman Antitrust Act and Wage Surveys to Organize the Healthcare Industry
- Searched
